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Abstract
Teriparatide is a bone-forming therapy for osteoporosis that increases bone quantity and
texture, with uncertain action on bone geometry. No data are available regarding its influ-
ence on bone strain. To investigate teriparatide action on parameters of bone quantity and
quality and on Bone Strain Index (BSI), also derived from DXA lumbar scan, based on the
mathematical model finite element method. Forty osteoporotic patients with fractures were
studied before and after two years of daily subcutaneous 20 mcg of teriparatide with dual X-
ray photon absorptiometry to assess bone mineral density (BMD), hip structural analysis
(HSA), trabecular bone score (TBS), BSI. Spine deformity index (SDI) was calculated from
spine X-ray. Shapiro-Wilks, Wilcoxon and Student’s t test were used for classical statistical
analysis. Auto Contractive Map was used for Artificial Neural Network Analysis (ANNs). In
the entire population, the ameliorations after therapy regarded BSI (-13.9%), TBS (5.08%),
BMD (8.36%). HSA parameters of femoral shaft showed a worsening. Dividing patients into
responders (BMD increase >10%) and non-responders, the first presented TBS and BSI
ameliorations (11.87% and -25.46%, respectively). Non-responders presented an ameliora-
tion of BSI only, but less than in the other subgroup (-6.57%). ANNs maps reflect the men-
tioned bone quality improvements. Teriparatide appears to ameliorate not only BMD and
TBS, but also BSI, suggesting an increase of bone strength that may explain the known
reduction in fracture risk, not simply justified by BMD increase. BSI appears to be a sensitive
index of TPD effect. ANNs appears to be a valid tool to investigate complex clinical systems.
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Introduction
Osteoporosis affects more than 75 million people in the United States, Europe and Japan. It
causes more than 8.9 million fractures annually worldwide, of which more than 4.5 million
occur in America and Europe. The lifetime risk of a wrist, hip or vertebral fracture has been
estimated to be in the order of 30% to 40% in developed countries [1].
The diagnosis of osteoporosis is based on the measurement of Bone Mineral Density
(BMD) with Dual X-ray Absorptiometry (DXA) [2]. Many studies indicate that the risk of frac-
ture doubles for each standard deviation reduction in BMD [3]. However, assessment of BMD
does not completely detect fracture risk. In fact, while the BMD at the spine and at the hip is
directly related to the risk of fracture [4], there is an overlap of BMD in patients with or without
fractures [5]. This poses a problem for the clinical assessment of fracture risk with BMD alone
for its lack of sensitivity [6]. The use of risk factors improves the sensitivity of the assessment
[7], but there is a need of further factors in addition to BMD that can predict fracture risk, like
the evaluation of bone micro-architectural structure [8]. Its direct examination can be done by
an invasive procedure like bone biopsy or indirectly by some non-invasive procedures, like
high-resolution peripheral quantitative computed tomography or magnetic resonance [9,10].
These procedures are, however, expensive or with high radiation dose and therefore not suitable
for screening. So, there is a need of a simple method for bone micro-architecture and texture
analysis. The Trabecular Bone Score (TBS) is a tool correlated with hystomorphometric bone
parameters that can be performed during a DXA scan [11]. The TBS evaluates local variations
in gray levels from the DXA image of the lumbar spine. It uses experimental variograms of 2D
projections images and can discriminate between samples with similar BMD but different 3D
trabecular micro-architecture. A high TBS value reflects a good vertebral microarchitectural tex-
ture, and vice versa. Previous studies showed that the TBS can predict the fracture risk partially
independently from BMD [12,13]. Other studies focused on the action of therapies for osteopo-
rosis on TBS. It has been shown that TBS ameliorates less with antiresorptive drugs like bisphos-
phonates than with bone forming agents like teriparatide [14,15].
Another recently developed bone structural parameter is the lumbar Bone Strain Index
(BSI), a stress and deformation vertebral parameter derived from a finite element analysis of
the lumbar DXA scan [16,17], that is based on a mathematical model called Finite Element
Method (FEM) [18].
BSI calculation is obtained using a constant strain triangular mesh, with the load applied to
upper surface and the constraints to the lower. The load applied to the vertebra is specific for
each patient and is based on relations between lumbar forces and patient’s weight and height
provided by Han study [19]. The mechanical properties of the model are defined in a stiffness
matrix assigning elastic modulus depending on local BMD according to Morgan’s equations
[20]. BSI represents the average strain inside the vertebra, obtained with a linear elastic analysis
and with the assumption that a higher strain level (high BSI) indicates a greater risk condition.
Recent clinical studies found a usefulness of BSI in identifying the osteoporotic patient’s sub-
group particularly prone to fragility fractures [21] and to characterize young patients affected
by secondary osteoporosis [22,23]. BSI increases linearly with stress and vertebral deformation,
so its reduction expresses an amelioration of bone status.
Hip Structural Analysis (HSA) is a DXA-derived tool that obtains transverse geometry
images acquired by densitometric scans. Its main structural parameters are the area of bone
inside the cross sectional area (CSA), the cross-sectional moment of inertia (CSMI) with the
section modulus (SECT_MOD) and the buckling ratio (BR), which are correlated to the maxi-
mal axial, bending and torsion forces [24]. Hip geometry, as well as hip BMD, has been shown
to have an independent correlation with the risk of hip fracture [2,25].
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Teriparatide (TPD, 1–34 recombinant human parathyroid hormone) is approved for the
treatment of primary and glucocorticoid-induced osteoporosis in patients with high fracture
risk [26,27]. A significant increase in TBS and spine BMD was reached with a two years treat-
ment with TPD in post-menopausal women [27,28]. Other studies with TPD demonstrated a
significant increase in proximal femur BMD, in a geometric parameter as average cortical
thickness, and in the outer- and endo-cortical diameters [29]. There was also an increase of
SEC_MOD and a reduction of BR [30–32]. Another work found that TBS significantly
increased with TPD, but did not significantly change with alendronate in glucocorticoid
induced osteoporosis [33].
Osteoporosis is a multi-factorial pathology, characterized by plenty of variables, which are
connected in a complex way that is difficult to investigate with classical standard statistical
methods. To approach the complexity of the problem we have employed a new methodology
based on an Artificial Neural Network (ANNs). ANNs are computational adaptive systems
inspired by the functioning processes of the human brain particularly adapted to solve non-
linear problems and to discover subtle trends and associations among variables (32,33). Based
on their learning through an adaptive way (i.e., extracting from the available data the informa-
tion needed to achieve a specific aim and to generalize the acquired knowledge), the ANNs
appear to be a powerful tool for data analysis in the presence of relatively small samples.
In this paper we have used a special kind of ANN architecture, the Auto Contractive Map
(AutoCM)[34,35]. This method of data mining is a new analytical process able to create a
semantic connectivity map in which non-linear associations are preserved, connections
schemes are explicated and the complex dynamics of adaptive interactions is captured. The
AutoCM approach has been applied in recent years to the analysis of a growing number of dif-
ferent clinical diseases, demonstrating its value in identifying significant associations between
clinical, serological and novel “omics” biomarkers [21,36–38]. Therefore, ANNs could be a
useful way to better understand the relationships between the numerous different variables
that play a role in osteoporosis. So, the aim of this study was to evaluate both with standard sta-
tistical and ANNs analysis the DXA bone quantity and quality parameters before and after
treatment with TPD in fractured osteoporotic patients.
Patients and methods
Patients
In this retrospective study 40 osteoporotic patients (29 women and 11 men) with multiple ver-
tebral osteoporotic fractures and treated with TPD were analyzed. All the women were in post-
menopause. The patients were followed at the “IRCCS Fondazione Ca’ Granda Ospedale Mag-
giore Policlinico”, Milan, Italy and at the “Istituto Auxologico Italiano IRCCS”, Milan, Italy.
All patients underwent a clinical examination, a spine X-ray exam to assess the spine defor-
mity index (SDI) [39,40], and a DXA exam to quantify hip and lumbar BMD, lumbar spine
TBS and BSI, and HSA. Patients were treated with daily subcutaneous 20 mcg of TPD (Forsteo,
Eli Lilly Company, Indianapolis, IN, USA) for 2 years. At the end of the treatment all patients
were assessed again with clinical examination, DXA and spine X-ray.
All the patients signed a written informed consent and local Ethical Committee approval
was obtained (Ethics Committee: Milano Area 2. Protocol N 2.0 BQ. 265_2017, 13th June
2017).
Methods
DXA data acquisition. Bone status was investigated with DXA (Hologic Discovery A,
Waltham, MA, USA, software version 13.3.0.1), according to the International Society for
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Clinical Densitometry (ISCD) guide lines [41]. All patients underwent two scans, a L1-L4 spine
scan and a hip scan. Fractured vertebrae were excluded from the analysis. TBS and BSI were
automatically obtained from the spine scans, while HSA was automatically obtained from the
hip DXA scan in three different regions: Narrow Neck (NN), Intertrochanteric Region (IT) and
Femoral Shaft (FS). Finally, Hip Axis Length (HAL, mm) and Shaft Neck Angle (degrees) were
also automatically measured from the hip scan. Beside BMD (g/cm2), in every hip region the
following parameters were considered: CSA (cm2), CSMI (cm4), BR, width (mm), and the sec-
tion modulus (SECT_MOD, cm3), which are related to axial and torsion strength. SECT_MOD
is derived from Cross Sectional Moment of Inertia (CSMI), that measures the torsional and
bending strengths contribution in relationship to the distance from the center to the outer corti-
cal of the considered section. BR is the ratio between the radius (the maximum distance between
the center of the bone section and its outer cortical) and the mean thickness of the cortical. It
provides a compressive and torsional loads cortical stability index.
Other data acquisition. In order to investigate the presence of vertebral fractures all
patients were imaged with antero-posterior and lateral X-ray of the spine at the beginning and
at the end of the pharmacological treatment. Finally, the SDI before and after therapy was cal-
culated using the semi-quantitative approach [42,43].
Statistics. We constructed a semantic connectivity map through Auto-CM system
(Semeion), a fourth generation ANNs, to offer some insight regarding the complex biological
connections between variables on study. The system highlights the natural links among vari-
ables with a graph based on minimum spanning tree theory, where distances among variables
reflect the weights of the ANN after a successful training phase. The Auto-Contractive Map
(Auto-CM) was born as a new ANNs and was designed at the Semeion Research Center
[44,45]. The Auto-CM system finds, by a specific learning algorithm, a square matrix of
weighted connections among the variables of any dataset. This matrix of connections presents
many suitable features: a) non linear associations among variables are preserved; b) connec-
tions schemes among clusters of variables are captured; c) complex similarities among vari-
ables become evident. Once an Auto-CM weights matrix is obtained, it is then filtered by a
minimum spanning tree (MST) algorithm generating a graph whose biological evidence has
already been tested in the medical field [3–6]. The ultimate goal of this data mining model is to
discover hidden trends and associations among variables, since this algorithm is able to create
a semantic connectivity map in which non linear associations are preserved and explicit con-
nection schemes are described. This approach shows the map of relevant connections between
and among variables and the principal hubs of the system. Hubs can be defined as variables
with the maximum amount of connections in the map. From a mathematical point of view the
specificity of Auto-CM algorithm is to minimize a complex cost function with respect to the
traditional ones.
Traditional minimization cost function:
E ¼ Min
�
XN
i
XN
j
XM
q
uqi � u
q
j � si;j
�
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N ¼ Number of Variables ðColumnsÞ;
M ¼ Number of Patterns ðRowsÞ:
Comparing the two cost functions it is evident how the traditional minimization includes
only second order effects, while the Auto-CM considers also a third order effect. Practically,
this means that the Auto-CM algorithm is able to discover variable similarities completely
embedded in the dataset and invisible to the other classical tools. This approach describes a
context which is typical of living systems, where a continuous time dependent complex change
in the variable value is present. Auto-CM can also learn under difficult circumstances such as
when the connections of the main diagonal of the second connections matrix are removed.
When the learning process is organized in this way, Auto-CM identifies specific relationships
between each variable and all others. Consequently, from an experimental point of view, it
appears that the ranking of its connections matrix is equal to the ranking of the joint probabil-
ity between each variable and the others. Auto-CM requires a training phase necessary to learn
how variables are interconnected. The learning algorithm of CM can be summarised in four
orderly steps: a) signal transfer from the input into the hidden layer; b) adaptation of the con-
nections value between the input layer and the hidden layer; c) signal transfer from the hidden
layer into the output layer; d) adaptation of the connections value between the hidden layer
and the output layer. The MST represents what could called the ‘nervous system’ of any data-
set. In fact, summing up all the connection strengths among all the variables, we get the total
energy of that system. The MST selects only the connections that minimize this energy, i.e. the
only ones that are really necessary to keep the system coherent. Consequently, all the links
included in the MST are fundamental, but, on the contrary, not every ‘fundamental’ link of the
dataset need to be in the MST. Such limit is intrinsic to the nature of MST itself. Every link
that gives rise to a cycle into the graph, that destroys the graph’s ‘treeness’, is eliminated, what-
ever its strength and meaningfulness. To fix this shortcoming and to better capture the intrin-
sic complexity of a dataset, it is necessary to add more links to the MST, according to two
criteria: (1) the new links have to be relevant from a quantitative point of view; (2) the new
links have to be able to generate new cyclic regular microstructures, from a qualitative point of
view. The additional links superimposed to MST graph generate a Maximally Regular Graph
(MRG).
MRG is the graph whose hubness function attains the highest value among all the graphs
generated by adding back to the original MST, one by one, the connections previously skipped
during the computation of the MST itself. In other words, starting from the MST, the MRG,
presenting the highest number of regular microstructures, highlights the most important con-
nections of the dataset. The resulting “diamond” expresses the complexity core of the system
and, in our specific case, the core of the syndrome.
AutoCM maps and minimum spanning tree have been applied to the entire population of
the study and also in two subgroups, “responders” and “non-responders” to the therapy, estab-
lished on the basis of a BMD criterium taken from the TPD pivotal registration trial [27], in
which the cut-off value of response was a 10% increase in lumbar spine BMD after treatment.
On the two groups, the Maximally Regular Graph (MRG) algorithm was then applied to the
Spanning Tree. This algorithm introduces new and more complex connections between vari-
ables not directly related in the spanning tree [34]. The resulting four maps show the relations
of the studied variables in the “responders” before (PreR) and after (PostR) therapy and the
same in the “non-responders” (preNR and PostNR, respectively).
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Regarding the classic statistical analysis, we first assessed the normality of data using the Sha-
piro-Wilks Test, and when the assumption was met (p< 0.05), data were presented as mean
with standard deviation. When normality was not satisfied, variables were presented as median
with interquartile range (IQR). The comparison of data before and after the treatment was per-
formed for all patients as well as for the subgroups (responders and non-responders). Student’s
t-test was used for data with a normal distribution, while for non-parametric data the Wilcoxon
signed rank test was used. A p value lower than 0.05 was considered statistically significant.
Results
In the entire population the mean age at the enrollment was 70 years ± 10.6 SD (range: 43–91).
Patients’ BMI before treatment was 25.9 ± 4.09, while after treatment it was 26.1 ± 4.6 kg/m2
(p = 0.542). Table 1 shows mean, median, SD, IQR, variation percentage and statistical significance
values of SDI and DXA parameters in the entire population, before and after TPD treatment.
Bone quality parameters BSI and TBS presented an amelioration after treatment, with a vari-
ation of -13.9% for BSI and 5.08% for TBS. BMD, which is the bone quantity parameter, showed
a significant increase of 8.36%. Hip geometry indexes of femoral shaft, CSA, SECT_MOD and
BR, worsened after treatment (-0.98%, -2.33%, 1.62%, respectively), while its BMD ameliorated
(0.23%). In our population 14 patients were “responders” and 26 were “non-responders”. Inter-
estingly, the percentage of gender composition was different between the two groups. In fact,
while “non responder” group was mainly composed by women (21/26, about 80%), the
“responder” group was quite balanced between males and females (8/14 females, about 55%).
When considering only the “responder” population, BMD showed a statistically significant
increase of +20.04%, while TBS and BSI showed a variation of +11.87% and -25.46% respec-
tively, which were both statistically significant. The only HSA parameter that showed a signifi-
cant variation was FS_CSMI (p = 0.01). On the contrary, when considering the “non-
responder” population, BSI was the only bone quality parameter showing a statistically signifi-
cant variation of -6.75%; neither BMD nor TBS showed a significant change. For HSA, a statisti-
cally significant change was found for all the FS parameters (CSMI, SECT_MOD and BR).
Table 2 shows mean/median values and the significance of the variation before and after
therapy of SDI and of the DXA parameters in the “responders” to TPD treatment.
Table 3 shows mean/median values and the significance of the variation before and after
TPD treatment of SDI and the DXA parameters in the “non-responders”. The two groups,
“responders” and “non-responders”, share the significant modification of only two variables:
BSI and FS_CSMI.
Fig 1 shows the connectivity map of all variables linked to the densitometric status before
TPD treatment, showing a spread around two nodes, FS_BMD and HAL, that appear to be
hubs. The distribution of nodes and their connections after therapy are showed in Fig 2, where
NN_SECT_MOD, correlating with bending and torsion resistance, gains a central position.
Fig 3A and 3B show the ANNs maps of the “responders” before and after therapy, where the
connections between variables increase after TPD, and FS_CSMI becomes the central hub. Fig
4A and 4B are the “non-responders” maps before and after treatment, showing a noticeable
paucity of interconnections, particularly before therapy. FS_CSMI looses its hub position in
favor of FS_CSA, index related to axial strength.
Discussion
In this study a population of patients with osteoporosis’ fragility fractures treated with subcuta-
neous daily injections of TPD, an osteoinductive agent known to ameliorate both mineral den-
sity and bone structure, was investigated before and after therapy. In the entire population
PLOS ONE ANNs and DXA indexes with TPD osteoporosis treatment
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Table 1. SDI and DXA parameters of the entire population (40 patients) before and after TPD therapy.
Mean/median SD/IQR Variation % p-value
NN_BMD Before TPD 0.740 0.112 2.92% 0.343
After TPD 0.761 0.205
NN_CSA Before TPD 2.347 0.401 1.62% 0.312
After TPD 2.385 0.454
NN_CSMI˚ Before TPD 2.197 1.112 1.87% 0.823
After TPD 2.239 1.147
NN_WIDTH Before TPD 3.345 0.352 0.27% 0.72
After TPD 3.354 0.384
NN_SECT_MOD Before TPD 1.213 0.302 1.33% 0.426
After TPD 1.229 0.333
NN_BR˚ Before TPD 13.480 3.930 -4.67% 0.214
After TPD 12.851 4.315
IT_BMD Before TPD 0.742 0.147 1.57% 0.374
After TPD 0.753 0.154
IT_CSA Before TPD 4.125 0.943 1.65% 0.365
After TPD 4.193 1.008
IT_CSMI˚ Before TPD 11.548 6.546 0.84% 0.635
After TPD 11.645 6.863
IT_WIDTH Before TPD 5.847 0.716 0.02% 0.985
After TPD 5.848 0.734
IT_SECT_MOD˚ Before TPD 3.626 1.580 -2.32% 0.302
After TPD 3.541 1.832
IT_BR Before TPD 11.439 3.549 -3.25% 0.79
After TPD 11.068 3.578
FS_BMD Before TPD 1.262 0.349 0.23% 0.03�
After TPD 1.265 0.358
FS_CSA Before TPD 3.624 1.239 -0.98% 0.034�
After TPD 3.588 1.282
FS_CSMI Before TPD 3.568 1.514 -1.27% 0.125
After TPD 3.522 1.835
FS_WIDTH Before TPD 3.076 0.269 0.26% 0.446
After TPD 3.084 0.285
FS_SECT_MOD Before TPD 2.256 0.840 -2.33% 0.005�
After TPD 2.203 0.855
FS_BR˚ Before TPD 3.558 1.285 1.62% 0.014�
After TPD 3.615 1.190
SHAFT_NECK_ANGLE Before TPD 128.895 5.141 0.25% 0.545
After TPD 129.222 5.159
SDI˚ Before TPD 8.000 6.000 12.50% 0.068
After TPD 9.000 6.000
HAL Before TPD 107.750 10.473 0.32% 0.432
After TPD 108.100 10.397
BMD Before TPD 0.745 0.143 8.36% <0.001�
After TPD 0.807 0.165
TBS˚ Before TPD 1.123 0.159 5.08% 0.019�
After TPD 1.180 0.158
(Continued)
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studied both TBS and BSI, indexes of bone texture and strain, respectively, showed a signifi-
cant amelioration, as well as BMD. For the last it is an expected and well-known result, while
there are only few data [46,47] about TBS, confirming its increase after TPD as reported in
other previous works [48]. As regards BSI, no data are available about its response to osteopo-
rosis’ treatment. In our study the value of BSI decreased significantly after TPD (-13.9%), and
this finding is compatible with an increase in bone strength. In fact, the amelioration of bone
structure and bone strength related to the vertebra increases the ability of the vertebra to sup-
port an external load, and thus reduces the internal strain. Being BSI the representation of the
internal strain of the vertebra, a lower value indicates a lower stress and strain level affecting
the vertebra, and consequently a lower fracture risk.
Considering the two groups in which the patients were divided, we notice that the only sig-
nificant difference in “non-responders” was the amelioration of BSI. Of note, differently from
“non responders”, the “responders” group was balanced in the gender composition with
almost the same percentage of both sexes. Thus, gender may have a certain specific impact on
BSI variations, despite this result needs to be confirmed in larger samples.
Regarding HSA parameters, significant variations were shown only at the femoral shaft, but
they are of very small absolute entity and so of doubtful clinical relevance. Differently to our
results, previous studies conducted in a larger set of patients did not found effects of TPD on
femoral shaft [30,32], but only on the other femoral regions. Overall, the significant variations
of both quantitative (BMD) and qualitative (TBS, BSI, femoral shaft HSA) DXA derived
parameters after TPD treatment are consistent with an improvement of bone resistance to
mechanical stresses[49,50].
The great number of variables considered in our study can complicate the comprehension
of the meaning of the correlations we found, and for this reason we also used an innovative
approach to statistical analysis, which is commonly used in artificial intelligence systems,
namely the neural network analysis (ANNs) with a potent data mining system. We can define
data mining as Data mining extraction of interesting (non-trivial, implicit, previously
unknown and potentially useful) patterns or knowledge from a huge amount of data. In medi-
cal field data mining represents a relatively new philosophy emerging with the advent of geno-
mic and functional data. The available techniques offered by classical statistics like Principal
Component Analysis of Hierarchical clustering suffer from a number of drawbacks due to the
complexity of possible interactions between risk factors, their non-linear influence on the dis-
ease occurrence and the considerable stochastic components. The more common algorithms
of linear projections of variables require generally a Gaussian distribution of data and have
limited power when the relationships between variables are non linear. Application of these
methods may loose important informations, and establish precise associations among variables
having only the contiguity as a known element is difficult. Another possible limitation of cur-
rently used statistical methods is that mapping is generally based on a specific kind of “dis-
tance” among variables (e.g. Euclidean, City block, correlation, etc), and gives origin to a
“static” projection of possible associations. In other words, the intrinsic dynamics due to active
Table 1. (Continued)
Mean/median SD/IQR Variation % p-value
BSI Before TPD 2.472 0.691 -13.90% <0.001�
After TPD 2.129 0.666
˚ = non-parametric distribution, with values presented as median with interquartile range (IQR) and compared with Wilcoxon signed rank test
� = statistically significant difference (p<0.05).
https://doi.org/10.1371/journal.pone.0229820.t001
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Table 2. SDI and DXA parameters of the “responders” (14 patients; 8 females and 6 males) before and after TPD therapy.
Mean/median SD/IQR Variation % p-value
NN_BMD Before TPD 0.706 0.103 3.56% 0.411
After TPD 0.732 0.164
NN_CSA Before TPD 2.352 0.361 5.32% 0.169
After TPD 2.477 0.518
NN_CSMI Before TPD 2.534 0.724 5.97% 0.062
After TPD 2.686 0.872
NN_WIDTH Before TPD 3.513 0.376 2.28% 0.093
After TPD 3.593 0.389
NN_SECT_MOD Before TPD 1.242 0.263 5.39% 0.146
After TPD 1.309 0.353
NN_BR˚ Before TPD 14.731 2.821 2.69% 0.972
After TPD 15.127 7.245
IT_BMD˚ Before TPD 0.691 0.130 6.02% 0.196
After TPD 0.732 0.140
IT_CSA Before TPD 4.109 0.877 6.49% 0.128
After TPD 4.376 1.017
IT_CSMI Before TPD 15.269 6.191 -6.00% 0.184
After TPD 14.353 8.014
IT_WIDTH Before TPD 6.251 0.791 0.21% 0.822
After TPD 6.264 0.810
IT_SECT_MOD Before TPD 3.869 1.066 3.28% 0.425
After TPD 3.996 1.080
IT_BR Before TPD 12.422 2.337 -4.55% 0.251
After TPD 11.856 2.364
FS_BMD Before TPD 1.237 0.245 0.29% 0.895
After TPD 1.241 0.247
FS_CSA Before TPD 3.801 0.921 0.59% 0.753
After TPD 3.823 0.927
FS_CSMI Before TPD 4.239 1.480 0.33% 0.01�
After TPD 4.253 1.546
FS_WIDTH Before TPD 3.210 0.281 0.28% 0.506
After TPD 3.219 0.280
FS_SECT_MOD Before TPD 2.447 0.919 -0.98% 0.795
After TPD 2.423 0.764
FS_BR˚ Before TPD 3.629 1.322 2.91% 0.650
After TPD 3.734 0.981
SHAFT_NECK_ANGLE Before TPD 131.021 5.185 -0.23% 0.709
After TPD 130.721 4.392
SDI Before TPD 8.000 5.000 12.50% 0.341
After TPD 9.000 4.500
HAL Before TPD 110.500 11.085 0.45% 0.611
After TPD 111.000 10.806
BMD Before TPD 0.736 0.172 20.04% <0.001�
After TPD 0.884 0.194
TBS˚ Before TPD 1.076 0.118 11.87% 0.019�
After TPD 1.204 0.182
(Continued)
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interactions of variables in living systems of the real world is completely lost. Auto-Cm system,
a fourth generation ANN, arises just to overcome these limitations. Auto-CM has been applied
in different medical contexts with interesting results demonstrating the ANNs’ usefulness in
easily “untangle the ball of yarn” of complex systems characterized by a lot of variables with
different significance [34–38]. In our population, we separately analyzed the maps obtained
before and after the treatment of TPD. The analysis clearly highlights a complex relationship
between bone quantity and bone quality parameters, with high adaptive weight among the
connections. When comparing pre- and post-treatment data in Tab. 1, we observe low abso-
lute variations of bone geometry parameters’ values, between 1 and 2%, but a noteable modifi-
cation of the connection maps in ANNs. In particular, in the pre-therapy map the variables are
divided into three leaves connected by two central hubs (Fig 1). They are HAL, indicating the
length of femoral neck, proportionally related to fracture risk, and FS_BMD. In the post-ther-
apy map (Fig 2) there is a change of the connections: FS_BMD migrates from central hub to
periphery and leaves its position to NN_SECT_MOD, which is an index of resistance to com-
pressive and flexural loads. This finding confirms the data of Stewart et al. and Jiang et al.
[51,52], which demonstrated a positive effect of TPD on bone strength with an increase of
CSA, that indicates a characteristic similar to SECT_MOD. Our data join to those described in
the few papers published regarding this item in humans [30,32], confirming the known effect
of TPD on the geometrical and structural bone parameters observed in animals [51,52]. Thus,
ANNs maps’ interconnections after TPD therapy change, with the grouping around the hub
CSMI, expression of increase in resistance to compressive loads, while in pre-treatment the
variables are more spread out.
Despite BSI did not modify its relationship with the other variables, it remains the index
that shows the greatest percentage of variation (about 14%), suggesting a significant ameliora-
tion of bone strength. This might be due to the presence of lots of variables related to femur
and just a few related to lumbar spine, that could explain an easy grow of the network affecting
the same region and a different location on the map of lumbar variables.
Considering our four models, namely PreR, PostR, PreNR and PostNR,in the networks
concerning the responders (Fig 3A and 3B) there is a high number of connections in the
MRG: PreR shows 9 hubs and 22 connections, whereas PostR 10 hubs and 33 connections.
This increase in the number of connections indicates an increase in the complexity of the sys-
tem. In fact, there is an improvement of 50% of connections and 11% of related hubs, and an
inclusion of the parameters referring to bone geometry not included in the PreR map
(NN_CSMI and NN_SECT_MOD, Fig 3B). In constructions’ science this is considered an
increase of the resistance of the system (building resistance to collapse) [53].
A significant difference also exists comparing PreNR and PostNR (Fig 4A and 4B), because
connections in the map increase significantly (400%), from 2 to 10, and there is a 133%
increase in hubs, namely from 3 to 7. This indicates a marked gain in complexity after the
treatment with TPD, including the cortical resistance parameters at all the considered femoral
regions (Fig 4B).
Table 2. (Continued)
Mean/median SD/IQR Variation % p-value
BSI˚ Before TPD 2.467 0.748 -25.46% 0.001�
After TPD 1.839 0.442
˚ = non-parametric distribution, with values presented as median with interquartile range (IQR) and compared with Wilcoxon signed rank test
� = statistically significant difference (p<0.05).
https://doi.org/10.1371/journal.pone.0229820.t002
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Table 3. SDI and DXA parameters of the “non-responders” (26 patients; 21 females and 5 males) before and after TPD therapy.
Mean/median SD/IQR Variation % p-value
NN_BMD Before TPD 0.758 0.114 0.67% 0.661
After TPD 0.763 0.116
NN_CSA Before TPD 2.345 0.428 -0.38% 0.775
After TPD 2.336 0.417
NN_CSMI˚ Before TPD 2.100 0.868 -3.21% 0.182
After TPD 2.032 0.856
NN_WIDTH Before TPD 3.255 0.309 -0.89% 0.327
After TPD 3.226 0.321
NN_SECT_MOD Before TPD 1.197 0.325 -0.95% 0.549
After TPD 1.185 0.320
NN_BR˚ Before TPD 12.763 3.969 -3.77% 0.131
After TPD 12.281 3.523
IT_BMD Before TPD 0.769 0.150 -0.59% 0.721
After TPD 0.765 0.162
IT_CSA Before TPD 4.133 0.993 -0.94% 0.567
After TPD 4.094 1.009
IT_CSMI˚ Before TPD 12.475 5.363 -4.43% 0.124
After TPD 11.923 5.461
IT_WIDTH Before TPD 5.629 0.577 -0.10% 0.933
After TPD 5.624 0.591
IT_SECT_MOD˚ Before TPD 3.490 1.256 -4.99% 0.066
After TPD 3.316 1.277
IT_BR Before TPD 10.553 2.421 2.04% 0.310
After TPD 10.768 2.794
FS_BMD Before TPD 1.256 0.216 -3.74% 0.002�
After TPD 1.209 0.199
FS_CSA Before TPD 3.595 0.713 -3.49% <0.01�
After TPD 3.470 0.681
FS_CSMI˚ Before TPD 3.374 1.289 -9.02% 0.03�
After TPD 3.070 1.264
FS_WIDTH Before TPD 3.004 0.238 0.26% 0.608
After TPD 3.012 0.266
FS_SECT_MOD˚ Before TPD 2.171 0.715 -9.94% <0.01�
After TPD 1.955 0.742
FS_BR˚ Before TPD 3.529 1.521 -0.36% 0.007�
After TPD 3.516 1.452
SHAFT_NECK_ANGLE Before TPD 127.750 4.833 0.52% 0.358
After TPD 128.415 5.436
SDI˚ Before TPD 7.500 6.500 13.33% 0.109
After TPD 8.500 6.250
HAL Before TPD 106.269 10.034 0.25% 0.560
After TPD 106.538 10.033
BMD Before TPD 0.750 0.128 2.19% 0.077
After TPD 0.767 0.134
TBS˚ Before TPD 1.156 0.161 -0.04% 0.404
After TPD 1.156 0.158
(Continued)
PLOS ONE ANNs and DXA indexes with TPD osteoporosis treatment
PLOS ONE | https://doi.org/10.1371/journal.pone.0229820 March 11, 2020 11 / 17
Comparing the PreNR group’s results with those of the PreR group, we noted 91% less con-
nections and 67% less hubs interconnected in the PreNR group (2 connections and 3 hubs in
the PreNR and 22 connections and 9 hubs in the PreR). Comparing PostNR with PostR there
are 70% less connections and 30% less interconnected nodes. So, “non-responders” have less
interconnections than “responders”, both before and after drug therapy. An ANNs map with
few connections seems to reflect a lower effect of TPD therapy, as indicated in literature [21].
This study points out the non-secondary role of DXA derived bone geometry parameters
that are worth of a specific insight for their importance in identifying patients who are respon-
sive or not to therapy. Another interesting finding is the reduction of BSI after TPD therapy,
that suggests an increasing of bone strength. Thus, BSI appears to be a sensitive index of TPD
effect, because it ameliorates even in the patients that do not present the expected relevant
increase of BMD or of other DXA quality parameters. Finally, this study highlights the utility
of the ANNs in the study of an item constituted by plenty of variables of different biological
significance.
Limitation of this work is the not great number of cases studied, that suggests the need to
extend this type of analysis to a larger group of patients. Another limitation of the study may
be the lack of familiarity in the use of this new method of analysis which, however, is the basis
of artificial intelligence which will increasingly tend to condition scientific activities as well.
Two conclusions arise from this study: In primis, TPD treatment appears to ameliorate not
only bone quantity (BMD), but also bone texture and bone strain. Bone quality parameters
(TBS, BSI, HSA), easily achieved by standard DXA scans, appear to be relevant in predicting
the pharmacological response and are worthwhile of a greater consideration in clinical
Table 3. (Continued)
Mean/median SD/IQR Variation % p-value
BSI Before TPD 2.413 0.668 -6.57% <0.01�
After TPD 2.255 0.657
˚ = non-parametric distribution, with values presented as median with interquartile range (IQR) and compared with Wilcoxon signed rank test
� = statistically significant difference (p<0.05)
https://doi.org/10.1371/journal.pone.0229820.t003
Fig 1. Semantic map showing the relations between the investigated anagraphic, anthropometric, densitometric,
biochemical and clinical parameters in the whole population before treatment.
https://doi.org/10.1371/journal.pone.0229820.g001
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Fig 2. Semantic map showing the relations between the investigated anagraphic, anthropometric, densitometric,
biochemical and clinical parameters in the whole population after treatment.
https://doi.org/10.1371/journal.pone.0229820.g002
Fig 3. Semantic map showing the relations between the investigated anagraphic, anthropometric, densitometric, biochemical and clinical
parameters in the “responders” before treatment (a) and after treatment (b).
https://doi.org/10.1371/journal.pone.0229820.g003
Fig 4. Semantic map showing the relations between the investigated anagraphic, anthropometric, densitometric, biochemical and clinical
parameters in the “non-responders” before treatment (a) and after treatment (b).
https://doi.org/10.1371/journal.pone.0229820.g004
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practice. Secondly, ANNs proves itself to be useful in understanding the relations between var-
iables of complex systems as those of multifactorial chronic diseases.
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